Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Buchner

Showing results (181-190 of 207) with videos related to

Pageof 21
Sort By:
EJNMMI Reports|August 18, 2024
PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancerGabriel T Sheikh, Christian Trapp, Nina-Sophie Schmidt-Hegemann, et al.
BJU International|June 25, 2011
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladderMatthias May, Patrick J Bastian, Maximilian Burger, et al.
European Urology|August 16, 2011
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladderPhilipp Nuhn, Matthias May, Maxine Sun, et al.
European Urology Focus|October 17, 2025
Gender Disparities in Health-related Quality of Life Outcomes Following Radical Cystectomy for Bladder CancerThilo Westhofen, Lennert Eismann, Gerald Bastian Schulz, et al.
Cancers|November 19, 2020
Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair AnalysisNina-Sophie Schmidt Hegemann, Paul Rogowski, Chukwuka Eze, et al.
The Journal of Urology|February 17, 2012
External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladderMatthias May, Patrick J Bastian, Sabine Brookman-May, et al.
World Journal of Urology|February 26, 2016
Efficacy and safety of the ZSI375 artificial urinary sphincter for male stress urinary incontinence: lessons learnedAlexander Kretschmer, Tanja Hüsch, Frauke Thomsen, et al.
Scandinavian Journal of Urology and Nephrology|March 11, 2011
Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladderMatthias May, Patrick J Bastian, Sabine Brookman-May, et al.
International Journal of Cancer|November 17, 2019
Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinomaJulia S Gerke, Martin F Orth, Yuri Tolkach, et al.
Annals of Surgical Oncology|January 20, 2011
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomyMatthias May, Edwin Herrmann, Christian Bolenz, et al.
Pageof 21

Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
EJNMMI Reports|August 18, 2024
PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancerGabriel T Sheikh, Christian Trapp, Nina-Sophie Schmidt-Hegemann, et al.
BJU International|June 25, 2011
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladderMatthias May, Patrick J Bastian, Maximilian Burger, et al.
European Urology|August 16, 2011
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladderPhilipp Nuhn, Matthias May, Maxine Sun, et al.
European Urology Focus|October 17, 2025
Gender Disparities in Health-related Quality of Life Outcomes Following Radical Cystectomy for Bladder CancerThilo Westhofen, Lennert Eismann, Gerald Bastian Schulz, et al.
Cancers|November 19, 2020
Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair AnalysisNina-Sophie Schmidt Hegemann, Paul Rogowski, Chukwuka Eze, et al.
The Journal of Urology|February 17, 2012
External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladderMatthias May, Patrick J Bastian, Sabine Brookman-May, et al.
World Journal of Urology|February 26, 2016
Efficacy and safety of the ZSI375 artificial urinary sphincter for male stress urinary incontinence: lessons learnedAlexander Kretschmer, Tanja Hüsch, Frauke Thomsen, et al.
Scandinavian Journal of Urology and Nephrology|March 11, 2011
Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladderMatthias May, Patrick J Bastian, Sabine Brookman-May, et al.
International Journal of Cancer|November 17, 2019
Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinomaJulia S Gerke, Martin F Orth, Yuri Tolkach, et al.
Annals of Surgical Oncology|January 20, 2011
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomyMatthias May, Edwin Herrmann, Christian Bolenz, et al.
Pageof 21